Resistant Cancer Cell Line Collection

Jindrich Cinatl
Dr Petra Joh-Forschungshaus
Frankfurter Stiftung für krebskranke Kinder
Frankfurt am Main, Germany

Wass-Michaelis Research Group
School of Biosciences
University of Kent
Kent, UK
Investigate Data for a single Drug: oxaliplatin
Oxaliplatin - Drug Information
Basic information about the drug is displayed below. This has been extracted from the Wikipedia entry for the drug - https://en.wikipedia.org/wiki/Oxaliplatin
Drug Structure
Oxaliplatin-2D-skeletal.png
Oxaliplatin-3D-balls.png
Clinical data
Trade names Eloxatin
AHFS/Drugs.com Monograph
MedlinePlus a607035
Pregnancy
category
US: D (Evidence of risk)
Routes of
administration
Intravenous
ATC code L01XA03 (WHO)
Pharmacokinetic data
Bioavailability Complete
Protein binding > 95%
Biological half-life ~10 - 25 minutes
Excretion Renal
Identifiers
Synonyms cisplatinum, platamin, neoplatin, cismaplat, cis-diamminedichloridoplatinum(II) (CDDP)
CAS Number 61825-94-3
PubChem CID 77994
DrugBank DB00526
ChemSpider 8062727
KEGG D01790
ChEMBL CHEMBL414804
PDB ligand CPT (PDBe, RCSB PDB)
Oxaliplatin Drug sensitivity Data
The table and barchart show all drug sensitivity data for oxaliplatin

In the bar chart resistant sub-lines are shown in a lighter shade of the parental cell line